Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 139-156 , September 2002

The role of low-molecular–weight heparin in cardiovascular diseases

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to Eric J. Topol, MD, FACC, Provost and Chief Academic Officer, Chairman, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, F 25, 9500 Euclid Ave, Cleveland, OH 44195.

PII: S0033-0620(02)70004-2

doi: 10.1053/pcad.2002.127679

Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 139-156 , September 2002

Article Tools

* Image Usage & Resolution